- Home
- ROIV vs WTS Comparison
ROIV vs WTS Comparison
Compare ROIV & WTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- WTS
- Stock Information
- Founded
- ROIV 2014
- WTS 1874
- Country
- ROIV United Kingdom
- WTS United States
- Employees
- ROIV N/A
- WTS N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- WTS Metal Fabrications
- Sector
- ROIV Health Care
- WTS Industrials
- Exchange
- ROIV Nasdaq
- WTS Nasdaq
- Market Cap
- ROIV 8.6B
- WTS 9.3B
- IPO Year
- ROIV N/A
- WTS 1986
- Fundamental
- Price
- ROIV $13.95
- WTS $282.29
- Analyst Decision
- ROIV Strong Buy
- WTS Buy
- Analyst Count
- ROIV 4
- WTS 4
- Target Price
- ROIV $15.50
- WTS $245.50
- AVG Volume (30 Days)
- ROIV 6.7M
- WTS 166.3K
- Earning Date
- ROIV 11-11-2025
- WTS 10-29-2025
- Dividend Yield
- ROIV N/A
- WTS 0.74%
- EPS Growth
- ROIV N/A
- WTS 12.86
- EPS
- ROIV N/A
- WTS 9.30
- Revenue
- ROIV $23,233,000.00
- WTS $2,285,700,000.00
- Revenue This Year
- ROIV N/A
- WTS $4.88
- Revenue Next Year
- ROIV $281.14
- WTS $4.32
- P/E Ratio
- ROIV N/A
- WTS $30.26
- Revenue Growth
- ROIV N/A
- WTS 2.96
- 52 Week Low
- ROIV $8.73
- WTS $177.59
- 52 Week High
- ROIV $14.48
- WTS $285.90
- Technical
- Relative Strength Index (RSI)
- ROIV 73.22
- WTS 58.56
- Support Level
- ROIV $11.85
- WTS $275.26
- Resistance Level
- ROIV $14.48
- WTS $285.01
- Average True Range (ATR)
- ROIV 0.42
- WTS 5.28
- MACD
- ROIV 0.19
- WTS -0.65
- Stochastic Oscillator
- ROIV 81.61
- WTS 71.14
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About WTS Watts Water Technologies Inc.
Watts Water Technologies Inc is a U.S.-based company that provides safety, energy efficiency, and water conservation products. Its product portfolio includes residential and commercial flow control products, which are sold for plumbing and hot water applications; HVAC and gas products, including commercial boilers, water heaters, heating solutions, etc.; drainage and water reuse products, including drainage products and engineered rainwater-harvesting solutions; and water quality products, including point-of-use and point-of-entry water filtration, conditioning, and scale prevention systems. Its products are marketed through brands like Watts, Apex, Bradley, Nexa, and others. Geographically, the company derives its key revenue from the Americas, followed by Europe and the APMEA region.